"A Lot Has Happened in Three Years." What’s Going on with the Parker Institute?

"A Lot Has Happened in Three Years." What’s Going on with the Parker Institute?

In 2016, the tech billionaire Sean Parker launched the Parker Institute for Cancer Immunotherapy with a $250 million investment. We check in with the institute’s Chief Science Officer to see how things are going and what’s been accomplished so far.

Read More

Filling Critical Gaps: Where Grants for Cancer Research Are Going so Far This Year

Filling Critical Gaps: Where Grants for Cancer Research Are Going so Far This Year

We’ve tracked nearly $80 million in new commitments for cancer research so far this year. With funders keen to leverage limited resources for maximum impact, a majority of that giving has gone to underfunded forms of cancer and young investigators. 

Read More

As Research Yields New Gains, More Money Flows for Genomic Medicine

As Research Yields New Gains, More Money Flows for Genomic Medicine

Using genomics to design far more precise and effective medical treatment plans has been called the “wave of the future.” Now, as breakthroughs increase, more funders are coming to the table to back biomedical research in this emerging field.

Read More

Four Ways Boehringer Ingelheim Funds Health and Science in Connecticut and Beyond

Four Ways Boehringer Ingelheim Funds Health and Science in Connecticut and Beyond

Boehringer Ingelheim and its BI Cares Foundation make a lot of grants in Connecticut, but also to researchers nationwide. What healthcare access, STEM, and research programs does this pharmaceutical giant back?

Read More

New Research for a Lethal Disease: How These Foundations Are Taking on Pancreatic Cancer

New Research for a Lethal Disease: How These Foundations Are Taking on Pancreatic Cancer

Pancreatic cancer often has a grim prognosis, typically evading early detection, and is difficult to treat. Three foundations are determined to change that with research grants for early detection and treatment of the disease.

Read More

“Expedite the Translation.” A Billionaire Keeps the Big Gifts for Medical Research Flowing

“Expedite the Translation.” A Billionaire Keeps the Big Gifts for Medical Research Flowing

A common theme of Len Blavatnik’s giving is an eagerness to support promising areas of medical research. Still, his biggest gift yet—$200 million to Harvard Medical School—has raised the usual questions about big philanthropy.

Read More

To Crack the Puzzles of Alzheimer's, a Foundation Takes a Laser Approach

To Crack the Puzzles of Alzheimer's, a Foundation Takes a Laser Approach

As Alzheimer’s disease inflicts an ever-rising toll on aging populations in the U.S. and overseas, the race is on for research breakthroughs. The Rainwater Charitable Foundation recently announced a major new prize focused on a key protein.

Read More

Medicine's Blind Spot: A Foundation Takes on Diagnostic Error

Medicine's Blind Spot: A Foundation Takes on Diagnostic Error

Diagnostic errors are the most common cause of medical errors, causing an estimated 40,000 to 80,000 deaths per year. But there is little funding for research on this problem. The Gordon and Betty Moore Foundation is looking to change that.

Read More

Neglected, But Devastating: Who's Funding Research for a Misunderstood Disease?

Neglected, But Devastating: Who's Funding Research for a Misunderstood Disease?

No mere “skin problem,” psoriasis is an incurable autoimmune disease afflicting 125 million people worldwide, carrying social and psychological impacts, and even the potential to shorten lifespans. But money for research is hard to come by. Who’s helping?

Read More

Not Just Sci-Fi: A Tech Couple Works To Achieve Immortality

Not Just Sci-Fi: A Tech Couple Works To Achieve Immortality

More deep-pocketed funders are interested in the age-old quest to live forever, in one form or another. We dig into the interesting story of Terasem Movement Foundation, founded by tech couple Martine and Bina Rothblatt.

Read More

Does Anyone Care? A Case Study of Funding Research on Rare Diseases

Does Anyone Care? A Case Study of Funding Research on Rare Diseases

Funding for rare diseases rarely comes from foundations or billionaire donors. Instead, it mostly comes from the families and friends of people affected. Here’s an example of how a small community of donors can underwrite significant research.

Read More

Payoff: Years of Investments in Parkinson’s Research is Yielding New Breakthroughs and Momentum

Payoff: Years of Investments in Parkinson’s Research is Yielding New Breakthroughs and Momentum

It’s hard to overstate the importance of patient private funding in the battle against Parkinson’s. Grantmakers in it for the long haul have often been behind gains made against the disease, with such successes now coming at a faster clip.

Read More

Vision, Daring, and Compassion: Paul Allen's Legacy of Philanthropy

Vision, Daring, and Compassion: Paul Allen's Legacy of Philanthropy

Paul Allen, who died recently, exemplified the best of big philanthropy. He embraced risk taking and cared deeply, journeying to the outer frontiers of scientific knowledge and to the front lines of the world’s biggest challenges. IP editor David Callahan assesses his legacy.

Read More

Path to Recovery: The Latest From a Leader in Breast Cancer Research Funding

Path to Recovery: The Latest From a Leader in Breast Cancer Research Funding

Susan G. Komen recently announced grants of $26 million to fund 62 new research projects that address some of the most difficult breast cancer cases. After years of troubles, this important funder has bounced back in a big way.

Read More

Go With the Gut: A Legacy Foundation and Silicon Valley Funder Team Up on Cell Research

Go With the Gut: A Legacy Foundation and Silicon Valley Funder Team Up on Cell Research

Helmsley Charitable Trust and Chan Zuckerberg Initiative, two heavy hitters in health research, are partnering to better understand cells in our intestines, as part of a larger moonshot project to catalogue all human cells.

Read More

Amid a Dearth of Dollars for Prostate Cancer Research, Two Funders Stay Focused

Amid a Dearth of Dollars for Prostate Cancer Research, Two Funders Stay Focused

Despite being one of the leading killers of men, claiming nearly 30,000 lives a year, prostate cancer research is seriously underfunded. Two grantmakers are leading the charge, but they can’t do it alone.

Read More

To Avert a Public Health Crisis, Three Funders Come Together

To Avert a Public Health Crisis, Three Funders Come Together

It’s not often that we see funders pooling money to create a not-for-profit generic drug company. In fact, we’ve never seen it before. Which is why the creation of Civica Rx deserves a close look.

Read More